EDGAR Filing Documents for 0001193125-17-046732

Form 8-K - Current report:

SEC Accession No. 0001193125-17-046732

Filing Date

2017-02-16

Accepted

2017-02-16 16:28:55

Documents

Period of Report

2017-02-16

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d348917d8k.htm	8-K	13296
2	EX-99.1	d348917dex991.htm	EX-99.1	18210
3	GRAPHIC	g348917dsp05.jpg	GRAPHIC	6214
	Complete submission text file	0001193125-17-046732.txt		41399

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884

Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220

Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 17618261
SIC: 2834 Pharmaceutical Preparations